<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-01-11" modified="2020-10-07" version="165">
<accession>Q9UL17</accession>
<name>TBX21_HUMAN</name>
<protein>
<recommendedName>
<fullName>T-box transcription factor TBX21</fullName>
<shortName>T-box protein 21</shortName>
</recommendedName>
<alternativeName>
<fullName>T-cell-specific T-box transcription factor T-bet</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor TBLYM</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TBX21</name>
<name type="synonym">TBET</name>
<name type="synonym">TBLYM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1998-09" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and characterization of a new member of T-box gene family.</title>
<authorList>
<person name="Yang S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Cell" volume="100" first="655" last="669">
<title>A novel transcription factor, T-bet, directs Th1 lineage commitment.</title>
<authorList>
<person name="Szabo S.J."/>
<person name="Kim S.T."/>
<person name="Costa G.L."/>
<person name="Zhang X."/>
<person name="Fathman C.G."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="10761931"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80702-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Hum. Genet." volume="117" first="16" last="26">
<title>Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.</title>
<authorList>
<person name="Akahoshi M."/>
<person name="Obara K."/>
<person name="Hirota T."/>
<person name="Matsuda A."/>
<person name="Hasegawa K."/>
<person name="Takahashi N."/>
<person name="Shimizu M."/>
<person name="Nakashima K."/>
<person name="Cheng L."/>
<person name="Doi S."/>
<person name="Fujiwara H."/>
<person name="Miyatake A."/>
<person name="Fujita K."/>
<person name="Higashi N."/>
<person name="Taniguchi M."/>
<person name="Enomoto T."/>
<person name="Mao X.-Q."/>
<person name="Nakashima H."/>
<person name="Adra C.N."/>
<person name="Nakamura Y."/>
<person name="Tamari M."/>
<person name="Shirakawa T."/>
</authorList>
<dbReference type="PubMed" id="15806396"/>
<dbReference type="DOI" id="10.1007/s00439-005-1285-0"/>
</citation>
<scope>INVOLVEMENT IN ANPAI</scope>
<scope>VARIANT GLN-33</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Science" volume="307" first="430" last="433">
<title>T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3.</title>
<authorList>
<person name="Hwang E.S."/>
<person name="Szabo S.J."/>
<person name="Schwartzberg P.L."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="15662016"/>
<dbReference type="DOI" id="10.1126/science.1103336"/>
</citation>
<scope>INTERACTION WITH GATA3</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2014" name="Biochem. Biophys. Res. Commun." volume="449" first="289" last="294">
<title>Deubiquitination and stabilization of T-bet by USP10.</title>
<authorList>
<person name="Pan L."/>
<person name="Chen Z."/>
<person name="Wang L."/>
<person name="Chen C."/>
<person name="Li D."/>
<person name="Wan H."/>
<person name="Li B."/>
<person name="Shi G."/>
</authorList>
<dbReference type="PubMed" id="24845384"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2014.05.037"/>
</citation>
<scope>DEUBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH USP10</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2016" name="Cell Rep." volume="15" first="2756" last="2770">
<title>T-bet activates Th1 genes through mediator and the super elongation complex.</title>
<authorList>
<person name="Hertweck A."/>
<person name="Evans C.M."/>
<person name="Eskandarpour M."/>
<person name="Lau J.C."/>
<person name="Oleinika K."/>
<person name="Jackson I."/>
<person name="Kelly A."/>
<person name="Ambrose J."/>
<person name="Adamson P."/>
<person name="Cousins D.J."/>
<person name="Lavender P."/>
<person name="Calder V.L."/>
<person name="Lord G.M."/>
<person name="Jenner R.G."/>
</authorList>
<dbReference type="PubMed" id="27292648"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.05.054"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCNT1</scope>
</reference>
<comment type="function">
<text evidence="1 3 7">Lineage-defining transcription factor which initiates Th1 lineage development from naive Th precursor cells both by activating Th1 genetic programs and by repressing the opposing Th2 and Th17 genetic programs (PubMed:10761931). Activates transcription of a set of genes important for Th1 cell function, including those encoding IFN-gamma and the chemokine receptor CXCR3. Activates IFNG and CXCR3 genes in part by recruiting chromatin remodeling complexes including KDM6B, a SMARCA4-containing SWI/SNF-complex, and an H3K4me2-methyltransferase complex to their promoters and all of these complexes serve to establish a more permissive chromatin state conducive with transcriptional activation (By similarity). Can activate Th1 genes also via recruitment of Mediator complex and P-TEFb (composed of CDK9 and CCNT1/cyclin-T1) in the form of the super elongation complex (SEC) to super-enhancers and associated genes in activated Th1 cells (PubMed:27292648). Inhibits the Th17 cell lineage commitment by blocking RUNX1-mediated transactivation of Th17 cell-specific transcriptinal regulator RORC. Inhibits the Th2 cell lineage commitment by suppressing the production of Th2 cytokines, such as IL-4, IL-5, and IL- 13, via repression of transcriptional regulators GATA3 and NFATC2. Protects Th1 cells from amplifying aberrant type-I IFN response in an IFN-gamma abundant microenvironment by acting as a repressor of type-I IFN transcription factors and type-I IFN-stimulated genes. Acts as a regulator of antiviral B-cell responses; controls chronic viral infection by promoting the antiviral antibody IgG2a isotype switching and via regulation of a broad antiviral gene expression program (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="1 4 6 7">Interacts with RUNX1, RUNX3, ITK, ABL1, RELA, CDK9 and KDM6B. The phosphorylated form (at Thr-303) interacts with NFATC2. Interacts with SMARCA4 in a KDM6B-dependent manner (By similarity). Interacts with CCTN1 (PubMed:27292648). Interacts with USP10 (PubMed:24845384). The phosphorylated form (at Tyr-530) interacts with GATA3 (PubMed:15662016).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
</interactant>
<interactant intactId="EBI-6664760">
<id>P23771</id>
<label>GATA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3922312">
<id>Q9UL17</id>
</interactant>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="3">T-cell specific.</text>
</comment>
<comment type="PTM">
<text evidence="1">Phosphorylations at Ser-53, Tyr-77, Ser-225 and Ser-513 are regulated by mTORC1. Phosphorylation at Tyr-530 is essential for its interaction GATA3. Phosphorylation at Tyr-220, Tyr-266 and Tyr-305 enhances its transcriptional activator activity. Phosphorylation at Thr-303 is required for its interaction with NFATC2.</text>
</comment>
<comment type="PTM">
<text evidence="1 6">Ubiquitinated at Lys-314, leading to its degradation by the proteasome. Ubiquitination is essential for controlling protein stability, binding to the T-box-binding element of the IFN-gamma promoter, and for interaction with NFATC2 through induction of phosphorylation at Thr-303 (By similarity). Deubiquitinated by USP10 leading to its stabilization (PubMed:24845384).</text>
</comment>
<comment type="disease" evidence="5">
<disease id="DI-02739">
<name>Asthma, with nasal polyps and aspirin intolerance</name>
<acronym>ANPAI</acronym>
<description>A condition consisting of asthma, aspirin sensitivity and nasal polyposis. Nasal polyposis is due to chronic inflammation of the paranasal sinus mucosa, leading to protrusion of edematous polyps into the nasal cavities.</description>
<dbReference type="MIM" id="208550"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<dbReference type="EMBL" id="AF093098">
<property type="protein sequence ID" value="AAF00055.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF241243">
<property type="protein sequence ID" value="AAF61243.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039739">
<property type="protein sequence ID" value="AAH39739.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11514.1"/>
<dbReference type="RefSeq" id="NP_037483.1">
<property type="nucleotide sequence ID" value="NM_013351.1"/>
</dbReference>
<dbReference type="SMR" id="Q9UL17"/>
<dbReference type="BioGRID" id="119027">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="DIP" id="DIP-61303N"/>
<dbReference type="IntAct" id="Q9UL17">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000177694"/>
<dbReference type="iPTMnet" id="Q9UL17"/>
<dbReference type="PhosphoSitePlus" id="Q9UL17"/>
<dbReference type="BioMuta" id="TBX21"/>
<dbReference type="DMDM" id="12230772"/>
<dbReference type="jPOST" id="Q9UL17"/>
<dbReference type="MassIVE" id="Q9UL17"/>
<dbReference type="MaxQB" id="Q9UL17"/>
<dbReference type="PaxDb" id="Q9UL17"/>
<dbReference type="PeptideAtlas" id="Q9UL17"/>
<dbReference type="PRIDE" id="Q9UL17"/>
<dbReference type="ProteomicsDB" id="84930"/>
<dbReference type="Antibodypedia" id="4021">
<property type="antibodies" value="674 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000177694">
<property type="protein sequence ID" value="ENSP00000177694"/>
<property type="gene ID" value="ENSG00000073861"/>
</dbReference>
<dbReference type="GeneID" id="30009"/>
<dbReference type="KEGG" id="hsa:30009"/>
<dbReference type="UCSC" id="uc002ilv.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="30009"/>
<dbReference type="DisGeNET" id="30009"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000073861.2"/>
<dbReference type="GeneCards" id="TBX21"/>
<dbReference type="HGNC" id="HGNC:11599">
<property type="gene designation" value="TBX21"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000073861">
<property type="expression patterns" value="Tissue enhanced (blood, bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="TBX21"/>
<dbReference type="MIM" id="208550">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604895">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UL17"/>
<dbReference type="OpenTargets" id="ENSG00000073861"/>
<dbReference type="PharmGKB" id="PA36362"/>
<dbReference type="eggNOG" id="KOG3585">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160397"/>
<dbReference type="HOGENOM" id="CLU_014430_8_2_1"/>
<dbReference type="InParanoid" id="Q9UL17"/>
<dbReference type="KO" id="K10166"/>
<dbReference type="OMA" id="WTEITPI"/>
<dbReference type="OrthoDB" id="374561at2759"/>
<dbReference type="PhylomeDB" id="Q9UL17"/>
<dbReference type="TreeFam" id="TF106341"/>
<dbReference type="PathwayCommons" id="Q9UL17"/>
<dbReference type="SIGNOR" id="Q9UL17"/>
<dbReference type="BioGRID-ORCS" id="30009">
<property type="hits" value="26 hits in 893 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="TBX21"/>
<dbReference type="GenomeRNAi" id="30009"/>
<dbReference type="Pharos" id="Q9UL17">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UL17"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q9UL17">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000073861">
<property type="expression patterns" value="Expressed in granulocyte and 119 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UL17">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000255"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001708">
<property type="term" value="P:cell fate specification"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071310">
<property type="term" value="P:cellular response to organic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001947">
<property type="term" value="P:heart looping"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0072676">
<property type="term" value="P:lymphocyte migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032703">
<property type="term" value="P:negative regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000320">
<property type="term" value="P:negative regulation of T-helper 17 cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000329">
<property type="term" value="P:negative regulation of T-helper 17 cell lineage commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000552">
<property type="term" value="P:negative regulation of T-helper 2 cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048304">
<property type="term" value="P:positive regulation of isotype switching to IgG isotypes"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045580">
<property type="term" value="P:regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00182">
<property type="entry name" value="TBOX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.820">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036960">
<property type="entry name" value="T-box_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001699">
<property type="entry name" value="TF_T-box"/>
</dbReference>
<dbReference type="InterPro" id="IPR018186">
<property type="entry name" value="TF_T-box_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11267">
<property type="entry name" value="PTHR11267"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00907">
<property type="entry name" value="T-box"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00937">
<property type="entry name" value="TBOX"/>
</dbReference>
<dbReference type="SMART" id="SM00425">
<property type="entry name" value="TBOX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01283">
<property type="entry name" value="TBOX_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01264">
<property type="entry name" value="TBOX_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50252">
<property type="entry name" value="TBOX_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-1058">Asthma</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="T-box transcription factor TBX21" id="PRO_0000184453">
<location>
<begin position="1"/>
<end position="535"/>
</location>
</feature>
<feature type="DNA-binding region" description="T-box" evidence="2">
<location>
<begin position="141"/>
<end position="326"/>
</location>
</feature>
<feature type="site" description="Essential for its interaction with RUNX1 and its ability to inhibit RUNX1 transcriptional activity and suppress TH17 lineage development" evidence="1">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="53"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="1">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="1">
<location>
<position position="118"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1" evidence="1">
<location>
<position position="220"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1" evidence="1">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="1">
<location>
<position position="303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1" evidence="1">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="513"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ITK" evidence="1">
<location>
<position position="530"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2240017." id="VAR_020252" evidence="5">
<original>H</original>
<variation>Q</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12721471." id="VAR_029275">
<original>I</original>
<variation>V</variation>
<location>
<position position="339"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JKD8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00201"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10761931"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15662016"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15806396"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24845384"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27292648"/>
</source>
</evidence>
<sequence length="535" mass="58328" checksum="51F351335598CEF2" modified="2000-05-01" version="1">MGIVEPGCGDMLTGTEPMPGSDEGRAPGADPQHRYFYPEPGAQDADERRGGGSLGSPYPGGALVPAPPSRFLGAYAYPPRPQAAGFPGAGESFPPPADAEGYQPGEGYAAPDPRAGLYPGPREDYALPAGLEVSGKLRVALNNHLLWSKFNQHQTEMIITKQGRRMFPFLSFTVAGLEPTSHYRMFVDVVLVDQHHWRYQSGKWVQCGKAEGSMPGNRLYVHPDSPNTGAHWMRQEVSFGKLKLTNNKGASNNVTQMIVLQSLHKYQPRLHIVEVNDGEPEAACNASNTHIFTFQETQFIAVTAYQNAEITQLKIDNNPFAKGFRENFESMYTSVDTSIPSPPGPNCQFLGGDHYSPLLPNQYPVPSRFYPDLPGQAKDVVPQAYWLGAPRDHSYEAEFRAVSMKPAFLPSAPGPTMSYYRGQEVLAPGAGWPVAPQYPPKMGPASWFRPMRTLPMEPGPGGSEGRGPEDQGPPLVWTEIAPIRPESSDSGLGEGDSKRRRVSPYPSSGDSSSPAGAPSPFDKEAEGQFYNYFPN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

